Medicine recalls
|
| |
| Singapore: Recall of Romesec Capsules 20mg from Singapore market (SIN11081P) for batch number #3963179 and 19010069 due to unacceptable product degradation |
| |
Health Sciences Authority (HSA) announces that a Dear Healthcare Professional Letter has been issued by Ranbaxy (Malaysia) Sdn. Bhd. to inform that two batches of Romesec Capsules (omeprazole) 20mg are being recalled due to the unacceptable product degradation, which may potentially result in the loss of product efficacy. Healthcare professionals using the affected batches are advised to follow the recommendations described in the letter and to return the affected capsules.
Please refer to the following website in HSA for details:
http://www.hsa.gov.sg/content/hsa/../Recall_of_Romesec_Capsules_20mg_from_Singapore_market.html
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Tuesday, Sep 10, 2019
Issued at HKT 16:00
|
| |
